Kah-Guan Au Eong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kah-Guan Au Eong has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan T. W. Au Eong
Singapore General Hospital, Department of General Surgery, Singapore, Singapore
9 shared publications - Jarryl H J Tsai
From the Lee Kong Chian School of Medicine (J.H.J.T., E.J.T., K-G.A.E), Nanyang Technological University, Singapore
4 shared publications - Benjamin H K Teo
Yong Loo Lin School of Medicine, National University of Singapore, Singapore
2 shared publications - Denise T. M. Au Eong
Institute of Mental Health, Buangkok Green Medical Park, Singapore, Singapore
2 shared publications - Ryan Le Jie Chiew
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
2 shared publications Aliza Jap
Changi General Hospital
1 shared publication
Latest Publications
- Open Access
- 10 December 2025
- Published by Elsevier in EULAR Rheumatology Open
- Vol. 1 (4) , 478-483
Cyclosporine A in the treatment of dry eye syndrome in patients with Sjögren’s disease—a systematic review
- 10 December 2025
- Published by Elsevier in EULAR Rheumatology Open
- Vol. 1 (4) , 478-483
Open AccessCyclosporine A in the treatment of dry eye syndrome in patients with Sjögren’s disease—a systematic review
- Open Access
- 14 July 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1556199
Prophylactic treatment of childhood myopia: a game-changer in combating the scourge of myopia?
The global prevalence of myopia has been increasing in the last few decades and is projected to reach 50% by the year 2050 in the absence of effective intervention measures. Each additional diopter (D) of myopia is associated with increased risk of ocular pathologies such as open-angle glaucoma (20%), posterior subcapsular cataract (21%), retinal detachment (30%), and myopic maculopathy (58%). Hence, there is a pressing need to control myopia progression to reduce the burden of its associated sight-threatening complications.Until now, the prevention of childhood myopia has been largely focused on secondary prevention, i.e., reducing the severity of the condition for those who already have myopia. Various pharmacologic and optical interventions are currently in use to retard myopia progression. Studies such as the landmark Atropine for the Treatment of Myopia 2 (ATOM2) and Low-Concentration Atropine for Myopia Progression (LAMP) trials in East Asia have provided robust evidence for the effect of atropine on myopia control. The prevailing theory on the mechanism of action is on atropine modulating muscarinic receptors in ocular tissues during development. This effect is dose-dependent: the weighted mean differences (WMD) in refraction and axial elongation per year was 0.73D and -0.26mm for high-concentration (0.5%-1%) atropine, 0.65D and -0.37mm for moderate concentration (0.1%-0.25%), and 0.35D and -0.11mm for low-concentration (0.005%-0.05%). Interestingly, the Atropine for the Treatment Of childhood Myopia in India (I-ATOM) trial on 100 Indian children with mild to moderate myopia found that topical 0.01% atropine reduced refraction progression but had no significant effect on axial elongation. The Pediatric Eye Disease Investigator Group (PEDIG) trialon 187 American children with low to moderate myopia found that nightly topical 0.01% atropine did not slow myopia progression or axial elongation after two years compared with placebo. Change in spherical equivalent refraction (SER) were -0.82D (atropine) and -0.80D (placebo; adjusted difference -0.02D; 95% CI, -0.19 to +0.15D; p=0.83) and axial length (AL) were 0.44mm (atropine) and 0.45mm (placebo; adjusted difference -0.002 mm; 95% CI, -0.106 to 0.102mm). It is worth noting that only a small proportion of participants (11%) in this trial was of East Asian descent, suggesting genetic and cultural or environmental influences on myopia progression. Balancing effectiveness and potential side effects, topical atropine 0.05% has been deemed to be the optimal concentration for myopia control. The commonly reported side effects include photophobia and mild blurry near vision due to pupil dilation and reduced accommodation. Most children adapt well over time, and the side effects are reversible upon cessation of treatment. Optical interventions with lenses designed for peripheral myopic defocus have been proven to be effective in signaling the eye to slow down its growth, resulting in slower myopia progression. For example, orthokeratology uses myopic shift and peripheral retinal defocus in addition to reshaping the cornea temporarily to achieve good unaided vision during lens-free periods in the daytime. Spectacle lenses with highly aspherical lenslets (HAL) and Defocus Incorporated Multiple Segments (DIMS) provide refractive correction for distance vision and peripheral myopic defocus simultaneously by converging some incoming light rays in front of the retina.to this new generation of myopia control spectacle lenses. Primary prevention of childhood myopia focuses on children who do not yet have myopia. Premyopia, as defined by the International Myopia Institute, is a refractive state between +0.75 and -0.50 D in children with risk factors such as increased AL, myopic parents, or environmental influences. While no strict age cutoff is given, children are considered at higher risk if their refractive error is <+0.75 D at age 6, ≤+0.50 D at ages 7-8, and ≤+0.25 D at ages 9-10. Current practices rely solely on behavioral modification to delay the onset of myopia in premyopes but we posit that in high risk groups, supplementing this with prophylactic treatment using pharmacologic and/or optical interventions may increase the efficacy of myopia control.Outdoor time and sunlight exposure have been hypothesized to prevent myopia development by stimulating light-sensitive dopamine release in the retina. Dopamine inhibits ocular axial elongation, the anatomical basis of myopia development. This relationship has been proven in several studies, including a 3-year clusterrandomized trial in Guangzhou, China, which demonstrated a 9.1% absolute reduction in myopia incidence and 23% relative reduction over three years with 40 minutes of outdoor activity added per school day (39.5% incidence in control group vs 30.4% in intervention group, p<0.001). Reduction of near work and longer viewing distances also exert a protective effect against myopia onset by reducing variation in accommodative demand and promote more uniform levels of retinal focus.Treating myopia before its onset in premyopes can potentially further reduce the risk of myopia-associated morbidities than current preventive strategies. Among the modalities, low-concentration atropine is currently the most evidence-supported intervention.Using topical low-concentration atropine in premyopes is a novel primary prevention strategy. A recent meta-analysis of three randomized controlled trials (RCT) and one non-RCT involving a total of 644 premyopic children aged 4-12 years highlighted its effectiveness in reducing rapid myopic shift (≥0.5 D/year, p<0.04) and myopia incidence (p=0.03) with 12-24 months of use as compared to placebo (Table 1). Evidence is now emerging that lenses with HAL and DIMS may be useful in treating premyopes. A RCT with 108 low-hyperopic (0 to +2.00 D) Chinese children aged 6-9.9 years demonstrated significantly slower axial elongation (p30 hours of...
- 14 July 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1556199
Open AccessProphylactic treatment of childhood myopia: a game-changer in combating the scourge of myopia?
The global prevalence of myopia has been increasing in the last few decades and is projected to reach 50% by the year 2050 in the absence of effective intervention measures. Each additional diopter (D) of myopia is associated with increased risk of ocular pathologies such as open-angle glaucoma (20%), posterior subcapsular cataract (21%), retinal detachment (30%), and myopic maculopathy (58%). Hence, there is a pressing need to control myopia progression to reduce the burden of its associated sight-threatening complications.Until now, the prevention of childhood myopia has been largely focused on secondary prevention, i.e., reducing the severity of the condition for those who already have myopia. Various pharmacologic and optical interventions are currently in use to retard myopia progression. Studies such as the landmark Atropine for the Treatment of Myopia 2 (ATOM2) and Low-Concentration Atropine for Myopia Progression (LAMP) trials in East Asia have provided robust evidence for the effect of atropine on myopia control. The prevailing theory on the mechanism of action is on atropine modulating muscarinic receptors in ocular tissues during development. This effect is dose-dependent: the weighted mean differences (WMD) in refraction and axial elongation per year was 0.73D and -0.26mm for high-concentration (0.5%-1%) atropine, 0.65D and -0.37mm for moderate concentration (0.1%-0.25%), and 0.35D and -0.11mm for low-concentration (0.005%-0.05%). Interestingly, the Atropine for the Treatment Of childhood Myopia in India (I-ATOM) trial on 100 Indian children with mild to moderate myopia found that topical 0.01% atropine reduced refraction progression but had no significant effect on axial elongation. The Pediatric Eye Disease Investigator Group (PEDIG) trialon 187 American children with low to moderate myopia found that nightly topical 0.01% atropine did not slow myopia progression or axial elongation after two years compared with placebo. Change in spherical equivalent refraction (SER) were -0.82D (atropine) and -0.80D (placebo; adjusted difference -0.02D; 95% CI, -0.19 to +0.15D; p=0.83) and axial length (AL) were 0.44mm (atropine) and 0.45mm (placebo; adjusted difference -0.002 mm; 95% CI, -0.106 to 0.102mm). It is worth noting that only a small proportion of participants (11%) in this trial was of East Asian descent, suggesting genetic and cultural or environmental influences on myopia progression. Balancing effectiveness and potential side effects, topical atropine 0.05% has been deemed to be the optimal concentration for myopia control. The commonly reported side effects include photophobia and mild blurry near vision due to pupil dilation and reduced accommodation. Most children adapt well over time, and the side effects are reversible upon cessation of treatment. Optical interventions with lenses designed for peripheral myopic defocus have been proven to be effective in signaling the eye to slow down its growth, resulting in slower myopia progression. For example, orthokeratology uses myopic shift and peripheral retinal defocus in addition to reshaping the cornea temporarily to achieve good unaided vision during lens-free periods in the daytime. Spectacle lenses with highly aspherical lenslets (HAL) and Defocus Incorporated Multiple Segments (DIMS) provide refractive correction for distance vision and peripheral myopic defocus simultaneously by converging some incoming light rays in front of the retina.to this new generation of myopia control spectacle lenses. Primary prevention of childhood myopia focuses on children who do not yet have myopia. Premyopia, as defined by the International Myopia Institute, is a refractive state between +0.75 and -0.50 D in children with risk factors such as increased AL, myopic parents, or environmental influences. While no strict age cutoff is given, children are considered at higher risk if their refractive error is <+0.75 D at age 6, ≤+0.50 D at ages 7-8, and ≤+0.25 D at ages 9-10. Current practices rely solely on behavioral modification to delay the onset of myopia in premyopes but we posit that in high risk groups, supplementing this with prophylactic treatment using pharmacologic and/or optical interventions may increase the efficacy of myopia control.Outdoor time and sunlight exposure have been hypothesized to prevent myopia development by stimulating light-sensitive dopamine release in the retina. Dopamine inhibits ocular axial elongation, the anatomical basis of myopia development. This relationship has been proven in several studies, including a 3-year clusterrandomized trial in Guangzhou, China, which demonstrated a 9.1% absolute reduction in myopia incidence and 23% relative reduction over three years with 40 minutes of outdoor activity added per school day (39.5% incidence in control group vs 30.4% in intervention group, p<0.001). Reduction of near work and longer viewing distances also exert a protective effect against myopia onset by reducing variation in accommodative demand and promote more uniform levels of retinal focus.Treating myopia before its onset in premyopes can potentially further reduce the risk of myopia-associated morbidities than current preventive strategies. Among the modalities, low-concentration atropine is currently the most evidence-supported intervention.Using topical low-concentration atropine in premyopes is a novel primary prevention strategy. A recent meta-analysis of three randomized controlled trials (RCT) and one non-RCT involving a total of 644 premyopic children aged 4-12 years highlighted its effectiveness in reducing rapid myopic shift (≥0.5 D/year, p<0.04) and myopia incidence (p=0.03) with 12-24 months of use as compared to placebo (Table 1). Evidence is now emerging that lenses with HAL and DIMS may be useful in treating premyopes. A RCT with 108 low-hyperopic (0 to +2.00 D) Chinese children aged 6-9.9 years demonstrated significantly slower axial elongation (p30 hours of...
- Open Access
- 25 February 2025
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 14 (6) , 100170
Tumbling pseudo-Krukenberg spindle
- 25 February 2025
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 14 (6) , 100170
Open AccessTumbling pseudo-Krukenberg spindle
- Open Access
- 21 December 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (1) , rjae783
Severe periocular ecchymosis following acupuncture therapy for dry eye: a report of two cases
Acupuncture is a complementary therapy used in many parts of the world to treat a variety of disorders. Two women aged 61 and 86 years old presented with painless bruising around their right eye for 3 and 10 days, respectively, following acupuncture therapy for dry eye. The younger woman was on oral acetylsalicylic acid 100 mg daily and it was her second episode of ocular bruising from a total of 20 therapy sessions. Clinical examination disclosed severe periocular ecchymosis in their right eye. There was no proptosis or globe perforation. The ecchymosis gradually resolved over a few weeks without any visual sequelae in both cases. Periocular acupuncture can cause severe periocular ecchymoses. Patients should be informed of this and other potentially sight-threatening complications associated with this form of treatment, and both acupuncture practitioners and ophthalmologists should be alert to recognize such complications early so that they can be appropriately managed.
- 21 December 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (1) , rjae783
Open AccessSevere periocular ecchymosis following acupuncture therapy for dry eye: a report of two cases
Acupuncture is a complementary therapy used in many parts of the world to treat a variety of disorders. Two women aged 61 and 86 years old presented with painless bruising around their right eye for 3 and 10 days, respectively, following acupuncture therapy for dry eye. The younger woman was on oral acetylsalicylic acid 100 mg daily and it was her second episode of ocular bruising from a total of 20 therapy sessions. Clinical examination disclosed severe periocular ecchymosis in their right eye. There was no proptosis or globe perforation. The ecchymosis gradually resolved over a few weeks without any visual sequelae in both cases. Periocular acupuncture can cause severe periocular ecchymoses. Patients should be informed of this and other potentially sight-threatening complications associated with this form of treatment, and both acupuncture practitioners and ophthalmologists should be alert to recognize such complications early so that they can be appropriately managed.
- Open Access
- 23 June 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e944342-e944342-4
Delayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report
Delayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report - Article abstract #944342
- 23 June 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e944342-e944342-4
Open AccessDelayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report
Delayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report - Article abstract #944342
- 10 June 2024
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 62 (10) , 156-159
Steroid-induced glaucoma: an avoidable cause of irreversible blindness
A man in his 70s on regular follow-up with an ophthalmologist for 10 years presented with blurry vision in his right eye for 4 days. He was diagnosed with elevated intraocular pressure (IOP) bilaterally 18 months earlier and treated with antiglaucoma eye-drops. On direct questioning, he admitted to using fixed combination tobramycin 0.3%/dexamethasone 0.1% eye-drops frequently to relieve ocular redness and discomfort in both eyes for 3.5 years without his ophthalmologist’s knowledge. Examination disclosed markedly elevated IOP, advanced optic disc cupping and tunnel vision due to steroid-induced glaucoma bilaterally. After cessation of the eye-drops and 2 weeks of antiglaucoma therapy, his IOP returned to normal and his visual field remained stable for 4 years.
- 10 June 2024
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 62 (10) , 156-159
Steroid-induced glaucoma: an avoidable cause of irreversible blindness
A man in his 70s on regular follow-up with an ophthalmologist for 10 years presented with blurry vision in his right eye for 4 days. He was diagnosed with elevated intraocular pressure (IOP) bilaterally 18 months earlier and treated with antiglaucoma eye-drops. On direct questioning, he admitted to using fixed combination tobramycin 0.3%/dexamethasone 0.1% eye-drops frequently to relieve ocular redness and discomfort in both eyes for 3.5 years without his ophthalmologist’s knowledge. Examination disclosed markedly elevated IOP, advanced optic disc cupping and tunnel vision due to steroid-induced glaucoma bilaterally. After cessation of the eye-drops and 2 weeks of antiglaucoma therapy, his IOP returned to normal and his visual field remained stable for 4 years.
- Open Access
- 3 June 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (6) , rjae244
Large corneal epithelial detachment as a complication of wound burping to release aqueous humor for elevated intraocular pressure following cataract surgery
Wound burping is a technique used to treat intraocular pressure spikes in the immediate postoperative period after cataract surgery. A 55-year-old man with no history of glaucoma presented with painless blurring of vision in his left eye following cataract surgery 20 days earlier. Ophthalmic examination disclosed elevated intraocular pressure, mild conjunctival hyperemia, corneal microcystic epithelial edema, and mild anterior chamber reaction. In an attempt to lower the intraocular pressure quickly, the corneal wound was ‘burped’ at the slitlamp. Upon burping the wound, a large epithelial bulla formed instantly in the cornea. The patient’s blinking caused the corneal epithelial bulla to burst and collapse. Examination the next day disclosed the detached epithelium had sloughed off completely. The epithelial defect healed gradually over 10 days. Wound burping to release aqueous humor after the corneal epithelium has healed over the surgical incision can result in corneal epithelial detachment and should be avoided.
- 3 June 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (6) , rjae244
Open AccessLarge corneal epithelial detachment as a complication of wound burping to release aqueous humor for elevated intraocular pressure following cataract surgery
Wound burping is a technique used to treat intraocular pressure spikes in the immediate postoperative period after cataract surgery. A 55-year-old man with no history of glaucoma presented with painless blurring of vision in his left eye following cataract surgery 20 days earlier. Ophthalmic examination disclosed elevated intraocular pressure, mild conjunctival hyperemia, corneal microcystic epithelial edema, and mild anterior chamber reaction. In an attempt to lower the intraocular pressure quickly, the corneal wound was ‘burped’ at the slitlamp. Upon burping the wound, a large epithelial bulla formed instantly in the cornea. The patient’s blinking caused the corneal epithelial bulla to burst and collapse. Examination the next day disclosed the detached epithelium had sloughed off completely. The epithelial defect healed gradually over 10 days. Wound burping to release aqueous humor after the corneal epithelium has healed over the surgical incision can result in corneal epithelial detachment and should be avoided.
- Open Access
- 1 April 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (4) , rjae231
Successful anatomical closure of a photographically documented 30-year-old idiopathic full-thickness macular hole following surgery for concurrent repair of an acute macula-on rhematogenous retinal detachment
A 62-year-old man with a 30-year-old photographically documented idiopathic full-thickness macular hole and visual acuity of 6/45 developed an acute macula-on rhegmatogenous retinal detachment in his left eye. A pars plana vitrectomy, internal limiting membrane peeling around the macular hole, fluid-air exchange, endolaser retinopexy around the peripheral retinal break and perfluoropropane (C3F8) internal tamponade were performed to repair the detached retina and macular hole. One month postoperatively, the patient developed a large peripheral circumferential retinal tear with shallow retinal detachment which necessitated scleral buckling, repeat vitrectomy, endolaser photocoagulation and C3F8 tamponade. The retina was successfully re-attached and the macula hole was closed. Three years post-vitrectomy, the repaired 30-year-old macular hole remained closed although the visual acuity remained unchanged at 6/45. In summary, we describe the successful anatomical closure of a 30-year-old idiopathic full-thickness macular hole which we believe to be the longest duration photographically documented macular hole closed following surgery.
- 1 April 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (4) , rjae231
Open AccessSuccessful anatomical closure of a photographically documented 30-year-old idiopathic full-thickness macular hole following surgery for concurrent repair of an acute macula-on rhematogenous retinal detachment
A 62-year-old man with a 30-year-old photographically documented idiopathic full-thickness macular hole and visual acuity of 6/45 developed an acute macula-on rhegmatogenous retinal detachment in his left eye. A pars plana vitrectomy, internal limiting membrane peeling around the macular hole, fluid-air exchange, endolaser retinopexy around the peripheral retinal break and perfluoropropane (C3F8) internal tamponade were performed to repair the detached retina and macular hole. One month postoperatively, the patient developed a large peripheral circumferential retinal tear with shallow retinal detachment which necessitated scleral buckling, repeat vitrectomy, endolaser photocoagulation and C3F8 tamponade. The retina was successfully re-attached and the macula hole was closed. Three years post-vitrectomy, the repaired 30-year-old macular hole remained closed although the visual acuity remained unchanged at 6/45. In summary, we describe the successful anatomical closure of a 30-year-old idiopathic full-thickness macular hole which we believe to be the longest duration photographically documented macular hole closed following surgery.
- Open Access
- 5 March 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (3) , rjae134
Severe astigmatism secondary to large intraocular lens pantoscopic tilt because of a malpositioned haptic following cataract surgery
An 80-year-old woman presented with painless blurring of vision and monocular diplopia in her left eye following routine phacoemulsification and monofocal intraocular lens (IOL) implantation 5 weeks earlier. Her uncorrected visual acuity (VA) was 6/60 correctable with pinhole to 6/21. Her best-corrected VA was 6/15 with a subjective refraction of −0.50DS/−5.25DCx37. Her corneal astigmatism was −1.25DCx74. Ophthalmic examination disclosed a severely tilted single-piece posterior chamber IOL in the capsular bag. The inferior portion of the optic was tilted posteriorly because of a twisted and malpositioned haptic. The patient underwent remedial surgery to untwist and reposition the IOL haptic which led to immediate improvement of the IOL position. Her uncorrected VA improved to 6/12−2 correctable with pinhole to 12+1 with an autorefraction of +0.25DS/−2.00DCx74 on the first postoperative day. One month postoperatively, her best-corrected VA was 6/12 with a refraction of +0.50DS/−2.50DCx82. Her final vision was limited by myopic macular degeneration.
- 5 March 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (3) , rjae134
Open AccessSevere astigmatism secondary to large intraocular lens pantoscopic tilt because of a malpositioned haptic following cataract surgery
An 80-year-old woman presented with painless blurring of vision and monocular diplopia in her left eye following routine phacoemulsification and monofocal intraocular lens (IOL) implantation 5 weeks earlier. Her uncorrected visual acuity (VA) was 6/60 correctable with pinhole to 6/21. Her best-corrected VA was 6/15 with a subjective refraction of −0.50DS/−5.25DCx37. Her corneal astigmatism was −1.25DCx74. Ophthalmic examination disclosed a severely tilted single-piece posterior chamber IOL in the capsular bag. The inferior portion of the optic was tilted posteriorly because of a twisted and malpositioned haptic. The patient underwent remedial surgery to untwist and reposition the IOL haptic which led to immediate improvement of the IOL position. Her uncorrected VA improved to 6/12−2 correctable with pinhole to 12+1 with an autorefraction of +0.25DS/−2.00DCx74 on the first postoperative day. One month postoperatively, her best-corrected VA was 6/12 with a refraction of +0.50DS/−2.50DCx82. Her final vision was limited by myopic macular degeneration.
- Open Access
- 15 November 2023
- Published by Springer Nature in Eye
- Vol. 38 (6) , 1027-1028
Changing paradigm in the management of childhood myopia
- 15 November 2023
- Published by Springer Nature in Eye
- Vol. 38 (6) , 1027-1028
Open AccessChanging paradigm in the management of childhood myopia